NCT03760237View on ClinicalTrials.gov

Cardiovascular Function in Acute Leukemia

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

May 6, 2024

Study Completion Date

May 6, 2024

Conditions
Leukemia, Myeloid, AcuteLeukemia, Lymphoid, AcuteCardiotoxicity
Interventions
OTHER

observation only

No intervention, observational study only

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT03760237 - Cardiovascular Function in Acute Leukemia | Biotech Hunter | Biotech Hunter